Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led, global pharmaceutical company has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions for cardiovascular disease management, to raise awareness on measuring blood pressure at home from the age of 18.
Glenmark and OMRON Healthcare India are collaborating on the “Take Charge @18” initiative to raise awareness about blood pressure screening at the right age of 18. The inlay card will be included in every OMRON Blood Pressure monitor sold in India, encouraging patients and caregivers to encourage at least four family members above 18 to start monitoring their blood pressure.
The campaign aims to reach 92,000 healthcare professionals and raise awareness among ten crore Indians, promoting early blood pressure screening and hypertension awareness. This aligns with Glenmark’s ‘Take Charge @18’ campaign and OMRON’s “Going for Zero” vision of preventive healthcare. Speaking about this collaboration, Alok Malik, Executive Vice President & Head of India Formulations, Glenmark Pharmaceuticals Ltd., said, ” Together, we aim to empower individuals to proactively safeguard their health from a young age.”